These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15223986)

  • 21. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
    Miyazaki Y; Matsuda M; DeFronzo RA
    Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
    Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
    Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
    Gorogawa S; Kaneto H; Matsuhisa M; Ohtoshi K; Kawamori D; Hazama Y; Yoshiuchi K; Yamasaki Y
    Diabetes Res Clin Pract; 2005 Jul; 69(1):1-4. PubMed ID: 15955381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
    Blondel O; Simon J; Chevalier B; Portha B
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects.
    Soop M; Nygren J; Brismar K; Thorell A; Ljungqvist O
    Clin Sci (Lond); 2000 Apr; 98(4):367-74. PubMed ID: 10731469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
    Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
    Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.
    Greco AV; Mingrone G; Mari A; Capristo E; Manco M; Gasbarrini G
    Gut; 2002 Dec; 51(6):870-5. PubMed ID: 12427792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
    Miyazaki Y; He H; Mandarino LJ; DeFronzo RA
    Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans.
    Thamer C; Haap M; Bachmann O; Zur Nieden T; Tschritter O; Stefan N; Fritsche A; Jacob S; Stumvoll M; Häring H
    Diabetologia; 2004 Jul; 47(7):1303-1305. PubMed ID: 15221137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.
    Carey AL; Bruce CR; Sacchetti M; Anderson MJ; Olsen DB; Saltin B; Hawley JA; Febbraio MA
    Diabetologia; 2004 Jun; 47(6):1029-37. PubMed ID: 15168015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity.
    Haluzík M; Sindelka G; Widimský J; Prázný M; Zelinka T; Skrha J
    J Hum Hypertens; 2002 Jan; 16(1):41-5. PubMed ID: 11840228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort.
    Hagström E; Hellman P; Lundgren E; Lind L; Arnlöv J
    Diabetologia; 2007 Feb; 50(2):317-24. PubMed ID: 17180664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
    Koopmans SJ; Ohman L; Haywood JR; Mandarino LJ; DeFronzo RA
    Diabetes; 1997 Oct; 46(10):1572-8. PubMed ID: 9313752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Handberg A; Vaag A; Vinten J; Beck-Nielsen H
    Diabetologia; 1993 Jul; 36(7):668-74. PubMed ID: 8395436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute blockade by endothelin-1 of haemodynamic insulin action in rats.
    Ross RM; Kolka CM; Rattigan S; Clark MG
    Diabetologia; 2007 Feb; 50(2):443-51. PubMed ID: 17187249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a 48-h fat infusion on insulin secretion and glucose utilization.
    Boden G; Chen X; Rosner J; Barton M
    Diabetes; 1995 Oct; 44(10):1239-42. PubMed ID: 7556964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.